Paper119643
Radioimmunoassay for type III procollagen peptide and its application to human liver disease.
Rohde H and 5 others. Eur J Clin Invest, 1979. Cited by 426 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Radioimmunoassay for type III procollagen peptide and its application to human liver disease. Papers, record 119643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/119643
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Radioimmunoassay for type III procollagen peptide and its application to human liver disease.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Liver Diseases, Alcoholic | Major topic |
| Procollagen | Major topic |
| Radioimmunoassay | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Animals | |
| Arthritis, Rheumatoid | |
| Ascitic Fluid | |
| Cattle | |
| Cross Reactions | |
| Female | |
| Humans | |
| Liver Cirrhosis, Alcoholic | |
| Male | |
| Middle Aged | |
| Peptides |
Source PubMed
Cited by69
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 426 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,943,908 | Is There a Diagnostic Miracle on the Horizon? Emerging Biomarkers in MASLD. | J Clin Med | 2025 | https://conductscience.org/library/papers/40943908 | PubMed |
| 37,686,599 | Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37686599 | PubMed |
| 35,332,383 | Fibrotic activity quantified in serum by measurements of type III collagen pro-peptides can be used for prognosis across different solid tumor types. | Cell Mol Life Sci | 2022 | https://conductscience.org/library/papers/35332383 | PubMed |
| 26,819,535 | Non-invasive assessment of liver fibrosis: Between prediction/prevention of outcomes and cost-effectiveness. | World J Gastroenterol | 2016 | https://conductscience.org/library/papers/26819535 | PubMed |
| 23,634,241 | The neo-epitope specific PRO-C3 ELISA measures true formation of type III collagen associated with liver and muscle parameters. | Am J Transl Res | 2013 | https://conductscience.org/library/papers/23634241 | PubMed |
| 17,708,599 | Noninvasive diagnosis of hepatic fibrosis in chronic hepatitis C. | World J Gastroenterol | 2007 | https://conductscience.org/library/papers/17708599 | PubMed |
| 17,203,518 | Usefulness of noninvasive transient elastography for assessment of liver fibrosis stage in chronic hepatitis C. | World J Gastroenterol | 2006 | https://conductscience.org/library/papers/17203518 | PubMed |
| 16,231,121 | Serum concentrations of aminoterminal propeptide of type III procollagen and propeptide of human type I procollagen in systemic lupus erythematosus. | Rheumatol Int | 2006 | https://conductscience.org/library/papers/16231121 | PubMed |
| 11,117,563 | Correlation between stellate cell activation and serum fibrosis markers in choline-deficient L-amino acid-defined diet-induced rat liver fibrosis. | Dig Dis Sci | 2000 | https://conductscience.org/library/papers/11117563 | PubMed |
| 11,081,389 | Predictive markers for hepatic veno-occlusive disease after hematopoietic stem cell transplantation in adults: a prospective single center study. | Bone Marrow Transplant | 2000 | https://conductscience.org/library/papers/11081389 | PubMed |
| 9,213,250 | Noninvasive determination of liver collagen content in chronic hepatitis. Multivariate regression modeling with blood chemical parameters as variables. | J Gastroenterol | 1997 | https://conductscience.org/library/papers/9213250 | PubMed |
| 8,680,545 | Serum type IV collagen in various liver diseases in comparison with serum 7S collagen, laminin, and type III procollagen peptide. | J Gastroenterol | 1996 | https://conductscience.org/library/papers/8680545 | PubMed |
| 8,572,734 | Synovial fluid and serum concentrations of aminoterminal propeptide of type III procollagen in healthy volunteers and patients with joint disease. | Ann Rheum Dis | 1996 | https://conductscience.org/library/papers/8572734 | PubMed |
| 8,508,013 | Study of serum procollagen type III peptide in patients with hepatic cirrhosis from a clinical point of view. | Clin Investig | 1993 | https://conductscience.org/library/papers/8508013 | PubMed |
| 8,375,627 | Hepatic fibrosis--current concepts of pathogenesis and therapy. | Gastroenterol Jpn | 1993 | https://conductscience.org/library/papers/8375627 | PubMed |
| 8,154,928 | Serum concentration of procollagen type I carboxyterminal propeptide in systemic sclerosis. | Arch Dermatol Res | 1994 | https://conductscience.org/library/papers/8154928 | PubMed |
| 8,153,923 | Fibroblast chemotactic response elicited by native bronchoalveolar lavage fluid from patients with fibrosing alveolitis. | Thorax | 1993 | https://conductscience.org/library/papers/8153923 | PubMed |
| 8,113,627 | Assessment of the fibrogenetic activity in chronic pancreatitis. The role of circulating levels of extracellular matrix components. | Int J Pancreatol | 1993 | https://conductscience.org/library/papers/8113627 | PubMed |
| 7,782,126 | Evaluation of serum type III procollagen peptide as an exposure marker in retired coal workers. | Int Arch Occup Environ Health | 1995 | https://conductscience.org/library/papers/7782126 | PubMed |
| 7,756,103 | CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in patients with liver and kidney diseases and epileptic patients. | Br J Clin Pharmacol | 1995 | https://conductscience.org/library/papers/7756103 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| COL3A1 | 1,281 | PubTator's text mining | https://conductscience.org/library/genes/1281 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/119643
GET https://conductscience.org/api/papers/v1/119643/cited_by?page=2